New RSV vaccine trial targets High-Risk adults in japan
NCT ID NCT07543380
First seen May 09, 2026 · Last updated Jun 04, 2026 · Updated 6 times
Summary
This study tests an RSV vaccine in adults aged 18-59 who have health conditions like chronic lung, heart, or kidney disease that put them at higher risk for severe RSV. The goal is to see if the vaccine triggers a strong immune response and is safe. Participants receive one shot and are followed for about 2 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fukuwa Clinic
RECRUITINGChuo-ku, Tokyo, 104-0031, Japan
-
Nihonbashi Sakura Clinic
RECRUITINGChuo-ku, Tokyo, 103-0025, Japan
-
Tenjin Sogo Clinic
RECRUITINGFukuoka, 810-0021, Japan
-
Tokyo-Eki Center-building Clinic
RECRUITINGChuo-ku, Tokyo, 103-0027, Japan
-
Tsuchiura Beryl Clinic
RECRUITINGTsuchiura, Ibaraki, 300-0062, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.